Hypophosphatasia Treatment Market Outlook: Strensiq Costs, Therapeutic Advances, and Future Opportunities
Hypophosphatasia Treatment Market Overview Hypophosphatasia is an ultra-rare inherited metabolic disorder caused by pathogenic changes in the ALPL gene, leading to deficient tissue-nonspecific alkaline phosphatase activity. The condition disrupts bone and dental mineralization and can range from severe perinatal manifestations to comparatively mild adult-onset disease. DelveInsight estimated...
0 Комментарии 0 Поделились 9 Просмотры 0 предпросмотр
BuzzingAbout https://www.buzzingabout.com